Wordt geladen...
ABL Kinase Domain Mutations in Patients with Chronic Myeloid Leukemia in Jordan
Mutations of the BCR-ABL tyrosine kinase domain constitute a major cause of resistance to tyrosine kinase inhibitors in patients with chronic myelogenous leukemia (CML). In this study, we analyzed peripheral blood samples from 185 Jordanian CML patients for ABL mutations, who were on imatinib for a...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Mary Ann Liebert, Inc.
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3483047/ https://ncbi.nlm.nih.gov/pubmed/23009571 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/gtmb.2012.0147 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|